Zobrazeno 1 - 10
of 28
pro vyhledávání: '"S. L. Sacks"'
Autor:
S L, Sacks, P D, Griffiths, L, Corey, C, Cohen, A, Cunningham, G M, Dusheiko, S, Self, S, Spruance, L R, Stanberry, A, Wald, R J, Whitley
Publikováno v:
Antiviral Research. 63:S19-S26
Viral shedding of HSV occurs frequently in infected individuals. HSV is shed asymptomatically from multiple anatomical sites and shedding, like exposure, is a significant risk for transmission. However, the relationship between shedding frequency, vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fa74bd29c47b7d380aacfa34d227c4
https://doi.org/10.1016/j.antiviral.2004.06.004
https://doi.org/10.1016/j.antiviral.2004.06.004
Autor:
M. Shuhart, Lawrence Corey, J. Ferrenberg, Sarah Holte, Chia C. Wang, Rebecca Engelberg, S. L. Sacks, Meei-Li Huang
Publikováno v:
Journal of viral hepatitis. 11(5)
Oral therapy for chronic hepatitis B remains suboptimal. Mathematical modelling of viral decay kinetics to rapidly assess potential antiviral regimens has proved valuable for human immunodeficiency virus and cytomegalovirus. We defined the kinetics o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1aabcafc58c6843d9c31e23abdde6e
https://pubmed.ncbi.nlm.nih.gov/15357650
https://pubmed.ncbi.nlm.nih.gov/15357650
Autor:
S L, Sacks, B, Wilson
Publikováno v:
Advances in experimental medicine and biology. 458
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8dd560ddd5455e42953cfbbe25642999
https://pubmed.ncbi.nlm.nih.gov/10549386
https://pubmed.ncbi.nlm.nih.gov/10549386
Publikováno v:
JAMA. 276(1)
To compare the efficacy and safety of episodic patient-initiated oral famciclovir with placebo in recurrent genital herpes.Randomized, double-blind, frequent-observation, dose-ranging study comparing twice-daily 125-mg, 250-mg, or 500-mg oral famcicl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7de2197ef306676cc736a6ce6ab4e61
https://pubmed.ncbi.nlm.nih.gov/9005266
https://pubmed.ncbi.nlm.nih.gov/9005266
Autor:
S L, Sacks
Publikováno v:
Seminars in dermatology. 15(2 Suppl 1)
The incidence of genital herpes continues to increase worldwide. Primary first-episode genital herpes are commonly associated with severe systemic symptoms. Primary first-episode lesions are usually bilateral and may from over a period of 10 days. No
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::708b131162b478dbd03e6f5a4e1d7ef5
https://pubmed.ncbi.nlm.nih.gov/8840414
https://pubmed.ncbi.nlm.nih.gov/8840414
Autor:
S L, Sacks
Publikováno v:
Current problems in dermatology. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9e6a6645ccd49aee4b3372829d9afc9
https://pubmed.ncbi.nlm.nih.gov/8743273
https://pubmed.ncbi.nlm.nih.gov/8743273
Autor:
W, Mahmood, S L, Sacks
Publikováno v:
Seminars in respiratory infections. 10(4)
The recognition of viruses as causes of pneumonia in both immunocompetent and immunocompromised hosts has expanded dramatically. The number of therapeutic agents available for treatment of these illness also has increased in the last decade. Each of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::524ae6deaa76f6577175a0657c737b65
https://pubmed.ncbi.nlm.nih.gov/8668855
https://pubmed.ncbi.nlm.nih.gov/8668855
Autor:
J J, Sasadeusz, S L, Sacks
Publikováno v:
Dermatologic clinics. 11(1)
Over the last few years we have seen the advent of effective antiviral drug therapy, the major ramifications being in the area of herpes infections. Acyclovir has become an established part of clinical practice, and other compounds are being increasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0feb17acd2a8413e87bf188bc60afaae
https://pubmed.ncbi.nlm.nih.gov/8382122
https://pubmed.ncbi.nlm.nih.gov/8382122
Publikováno v:
Advances in experimental medicine and biology. 312
Resistance of herpes simplex virus to acyclovir is a problem of growing clinical importance. Acyclovir-resistance can be due either to mutations in the viral thymidine kinase gene or in the viral DNA polymerase gene. Although clinical resistance has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7364d9eac5faa9a7ad1d1901fd8a35a
https://pubmed.ncbi.nlm.nih.gov/1325102
https://pubmed.ncbi.nlm.nih.gov/1325102
Publikováno v:
Journal of Antimicrobial Chemotherapy. 46:324-325
SmithKline Beecham Consumer Healthcare, St George’s Avenue, Weybridge, Surrey KT14 0DE; The Ridge Medical Practice, Great Horton, Bradford, Yorkshire BD7 3EE for and on behalf of Profiad Ltd, 20-24 Vachel Road, Reading RG1 1NY, UK; Viridae Clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::992bd2e948ca9ad4dfe91fdb9ca064c6
https://doi.org/10.1093/jac/46.2.324
https://doi.org/10.1093/jac/46.2.324